Daniel N. Swisher JR - 03 Jan 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
President and COO
Signature
By: /s/Adam Guttmann, as attorney in fact For: Daniel N Swisher, Jr.
Issuer symbol
JAZZ
Transactions as of
03 Jan 2022
Transactions value $
-$212,760
Form type
4
Filing time
05 Jan 2022, 15:39:52 UTC
Previous filing
03 Sep 2021
Next filing
09 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Tax liability -$213K -1.62K -3.24% $131.01 48.5K 03 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
F2 Includes 147 and 62 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28 and November 30, 2021, respectively.